Following positive research data , retatrutide, a new peptide treatment for treating adult-onset diabetes , has obtained conditional approval from Great Britain's Drug and Regulatory Agency ( MHRA https://deaconflpi995462.thelateblog.com/41597015/retatrutide-medication-peptide-uk-approval-and-access